Stay updated on Oral Zavegepant for Migraine Prevention Clinical Trial

Sign up to get notified when there's something new on the Oral Zavegepant for Migraine Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Zavegepant for Migraine Prevention Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value 05 03 7 has been updated to 06 06 8 on the webpage, indicating a recent change in the data related to Medical and healthcare publications and documentation.
    Difference
    1.0%
    Check dated 2024-06-06T14:33:40.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of certain medical or healthcare-related publications or documentation. This change may reflect new information or additional entries in the relevant category.
    Difference
    0.3%
    Check dated 2024-05-22T21:21:02.000Z thumbnail image
  8. Check
    40 days ago
    Change Detected
    Summary
    The value 'Active, not recruiting -21' on the webpage has been updated to 'Terminated Strategic decision to discontinue the study based on adjusted clinical development plan. This decision is not based on any safety concerns.' This change likely indicates that the study has been terminated for strategic reasons and not due to safety issues.
    Difference
    4%
    Check dated 2024-05-04T09:56:45.000Z thumbnail image
  9. Check
    43 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:50:49.000Z thumbnail image

Stay in the know with updates to Oral Zavegepant for Migraine Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Zavegepant for Migraine Prevention Clinical Trial page.